The California Institute for Regenerative Medicine has awarded a group of researchers $20 million for work on six compounds. Recipients are tasked with developing drugs for clinical trials within the next four years. We at the MPD Foundation are excited about this new development and investment in research that could help MPD patients.
MAJOR GRANT AWARDED FOR LEUKEMIA & MYELOFIBROSIS
MPNRF | May 3, 2020